SCHEMBL4122595

SCHEMBL4122595

CCC(C(=O)O)c1ccc(NC2=NC(=O)/C(=C\c3cc4ccccc4cc3OCc3ccccc3)S2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTP4A3 O75365 3/20 0.46
CISD1 Q9NZ45 1/20 0.38
PTPN1 P18031 3/20 0.37
F2 P00734 2/20 0.36
F10 P00742 2/20 0.36
PRSS1 P07477 2/20 0.36
PRSS2 P07478 2/20 0.36
F7 P08709 2/20 0.36
F3 P13726 2/20 0.36
PRSS3 P35030 2/20 0.36
CTSV O60911 1/20 0.36
CTSL P07711 1/20 0.36
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
TTR P02766 1/20 0.36
BLM P54132 1/20 0.36
PLA2G1B P04054 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4122600 1.00 PTP4A3 (0.46) PTP4A3CISD1PTPN1F2F10
SCHEMBL4635065 0.88 PTP4A3 (0.43) PTP4A3CISD1PTPN1F2F10
SCHEMBL27718281 0.88 PTP4A3 (0.45) PTP4A3CISD1PTPN1CTSVCTSL
SCHEMBL27718161 0.85 PTP4A3 (0.45) PTP4A3CISD1PTPN1CTSVCTSL
Propionic Acid SCHEMBL4133739 0.85 PTP4A3 (0.47) PTP4A3CISD1PTPN1CTSVCTSL
Acetic Acid SCHEMBL4125639 0.85 PTP4A3 (0.48) PTP4A3CISD1PTPN1CTSVCTSL
Acetic Acid SCHEMBL4125635 0.85 PTP4A3 (0.48) PTP4A3CISD1PTPN1CTSVCTSL
SCHEMBL4125736 0.85 PTP4A3 (0.50) PTP4A3CISD1PTPN1MEN1KMT2A
SCHEMBL4125733 0.85 PTP4A3 (0.50) PTP4A3CISD1PTPN1MEN1KMT2A
SCHEMBL4129153 0.84 PTP4A3 (0.46) PTP4A3CISD1PTPN1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US claimed
EP-1934192-A1 THIAZOLINONES AND OXAZOLINONES AND THEIR USE AS PTP1B INHIBITORS Torrent Pharmaceuticals Ltd (IN) 2008-06-25 EP claimed
WO-2007032028-A1 THIAZOLINONES AND OXAZOLINONES AND THEIR USE AS PTP1B INHIBITORS TORRENT PHARMACEUTICALS LTD. (IN) 2007-03-22 WO claimed
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors PTPRF, PTPA, PTPRJ PTP4A3 26/4885CISD1 3041/4885PTPN1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.